Table 1. Cell surface expression of CD27 and CD70 in cancer cell lines.
Cell line | Type | CD70 | CD27 |
---|---|---|---|
Raji | NHL | +++ | +++ |
U266 | MM | +++ | − |
Amo-1 | MM | +++ | − |
RPMI | MM | ++ | −/+ |
INA6 | MM | − | − |
KMS-11 | MM | ++ | − |
MM1.S | MM | ++ | − |
KMS12.BM | MM | +++ | +++ |
JNN3 | MM | +++ | − |
Mino | MCL | +++ | − |
Jeko-1 | MCL | +++ | − |
Rec-1 | MCL | +++ | − |
Granta-519 | MCL | +++ | + |
MJ(G11) | CTCL | +++ | − |
JVM3 | CLL | +++ | − |
Ramos-Ra1 | Burkitt | ++ | +++ |
BJAB | Burkitt | +++ | −/+ |
Daudi | Burkitt | ++ | − |
SuDHL6 | DLBCL | ++ | − |
Panc-1 | Pancreatic cancer | +++ | + |
Panc89 | Pancreatic cancer | ++ | + |
PancTu1 | Pancreatic cancer | − | − |
MiaPaca-2 | Pancreatic cancer | − | − |
Colo357 | Pancreatic cancer | − | − |
A498 | RCC | +++ | − |
786-O | RCC | +++ | + |
FaDu | SCC | − | − |
HLaC-78 | SCC | −/+ | − |
WM-35 | Melanoma | −/+ | − |
WM-3211 | Melanoma | − | − |
WM-115 | Melanoma | +++ | − |
WM-1552C | Melanoma | +/++ | − |
WM793 | Melanoma | −/+ | − |
WM-3248 | Melanoma | ++ | − |
SK-mel-19 | Melanoma | − | − |
MV3 | Melanoma | − | − |
WM-852 | Melanoma | + | − |
WM-451-LU | Melanoma | − | − |
WM-1205Lu | Melanoma | +++ | − |
BLM | Melanoma | − | − |
OAW-42 | Ovarian cancer | −/+ | − |
SKOV-3 | Ovarian cancer | + | − |
OVCAR3 | Ovarian cancer | ++ | − |
GaMG | Glioblastoma | −/+ | − |
U87 | Glioblastoma | + | − |
U343 | Glioblastoma | + | − |
Ln18 | Glioblastoma | − | − |
Abbreviations: CLL, chronic lymphocytic leukemia; CTCL, cutaneous T-cell lymphoma; DLBCL, diffuse large B-cell lymphoma; MCL, mantle cell lymphoma; MM, multiple myeloma; NHL, non-Hodgkin lymphoma; RCC, renal cell carcinoma; SCC, squamous cell cancer. Cells were analyzed by using FACS. +++ indicates very high expression, for example, like Mino cells (Figure 5A), ++ indicates high expression, for example, like OVCAR3 cells (Figure 5A),+indicates significant expression, − indicates lack of significant binding